- Tipos de Cáncer
Tipos de Cáncer
Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.A a la Z - Tratamiento
Tratamiento del Cáncer
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
- Riesgo de concer y prevencion
- Drogas de Cáncer
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
- Lidiando
Lidiando con el Cáncer
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
- Profesionales de la salud
- Estudios Clínicos
Notas para enfermeros 
¿Cuál es mi riesgo? k? 
OncoPilot: Manejando su experiencia del cáncer 
OncoLink Cancer Blogs
Community Events Calendar 
Abramson Cancer Center 
NCI CANCERLIT® Search: Tuberous Sclerosis - October 2001
National Cancer Institute®
Ultima Vez Modificado: 21 de noviembre del 2001
Table of Contents
1
UI - 21411272
AU - Franz DN; Brody A; Meyer C; Leonard J; Chuck G; Dabora S; Sethuraman G;
TI -
Colby TV; Kwiatkowski DJ; McCormack FX
Mutational and radiographic analysis of pulmonary disease consistent
with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in
women with tuberous sclerosis.
SO - Am J Respir Crit Care Med 2001 Aug 15;164(4):661-8
AD - Department of Pediatrics, University of Cincinnati College of Medicine,
Cincinnati, Ohio, USA. d.franz@chmcc.org
Lymphangioleiomyomatosis (LAM) and multifocal micronodular pneumocyte
hyperplasia (MMPH) produce cystic and nodular disease, respectively, in
the lungs of patients with tuberous sclerosis. The objective of this
study was to prospectively characterize the prevalence, clinical
presentation, and genetic basis of lung disease in TSC. We performed
genotyping and computerized tomographic (CT) scanning of the chest on 23
asymptomatic women with tuberous sclerosis complex (TSC). Cystic
pulmonary parenchymal changes consistent with LAM were found in nine
patients (39%). These patients tended to be older than cyst-negative
patients (31.9 +/- 7.6 yr versus 24.8 +/- 11.6 yr, p = 0.09). There was
no correlation between presence of cysts and tobacco use, age at
menarche, history of pregnancy, or estrogen-containing medications.
Three of the cyst-positive patients had a prior history of pneumothorax.
Pulmonary function studies revealed evidence of gas trapping but normal
spirometric indices in the cyst-positive group. All nine cyst-positive
patients had angiomyolipomas (AML), which were larger (p < 0.05) and
more frequently required intervention (p = 0.08) than cyst-negative
patients (8 of 14 with AMLs, p < 0.05). Ten patients (43%) had pulmonary
parenchymal nodules. Pulmonary nodules were more common in women with
cysts (78% versus 21%, p < 0.05), and 52% of all patients had either
cystic or nodular changes. TSC2 mutations were identified in all
cyst-positive patients who were tested (n = 8), whereas both TSC1 and
TSC2 mutations were found in patients with nodular disease. Correlation
of the mutational and radiographic data revealed one pair of sisters who
were discordant for cystic disease, two mother- daughter pairs who were
discordant for nodular disease, and no clear association between cyst
development and a specific mutational type. This prospective analysis
demonstrates that cystic and nodular pulmonary changes consistent with
LAM and MMPH are common in women with TSC.
2
UI - 21295699
AU - Khare L; Strizheva GD; Bailey JN; Au KS; Northrup H; Smith M; Smalley
TI -
SL; Henske EP
A novel missense mutation in the GTPase activating protein
homology region of TSC2 in two large families with tuberous
sclerosis complex.
SO - J Med Genet 2001 May;38(5):347-9
3
UI - 84216651
AU - Simmons K
TI -
Early diagnosis, genetic marker sought for tuberous sclerosis.
SO - JAMA 1984 Jun 15;251(23):3061-3
The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
